The HealthSignals Brief

Biweekly intelligence on pharma & healthcare in Latin America. Regulatory moves, deals, and market signals — in 5 minutes, every other week.

THE HEALTHSIGNALS BRIEF
A fortnightly PDF compiling our analysis on pharma, medical devices, health policy and epidemiology across Latin America and the United States.
Step 1 of 2 · Free. Work email for instant access. Unsubscribe anytime. By subscribing you agree to receive The HealthSignals Brief by email and accept our Privacy Policy.

What you get

  • Regulatory radar: COFEPRIS, ANVISA, ANMAT and FDA moves that affect Latin American markets
  • Deal flow: M&A, licensing, and market-entry signals across pharma and healthcare
  • Market signals: the trends behind the headlines, curated from hundreds of sources

Built for decision-makers at pharma companies, CROs, health agencies, and investors covering the region.